The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Predictors of New-Onset Kidney Disease in a Community-Based Population
Abstract
Context Kidney disease is associated with an increased risk for the development of cardiovascular disease and end-stage renal disease; however, risk factors for kidney disease have not been well studied. Objective To identify predictors of the development of new-onset kidney disease. Design, setting, and participants A community-based, longitudinal cohort study of 2585 participants who attended both a baseline examination in 1978-1982 and a follow-up examination in 1998-2001, and who were free of kidney disease at baseline. Main outcome measures Kidney disease was assessed by the Modification of Diet in Renal Disease Study equation and defined by a glomerular filtration rate (GFR) in the fifth or lower percentile ( Results At baseline, there were 1223 men and 1362 women, with a mean age of 43 years, who were free of preexisting kidney disease. After a mean follow-up of 18.5 years, 244 participants (9.4%) had developed kidney disease. In multivariable models, baseline age (odds ratio [OR], 2.36 per 10-year increment; 95% confidence interval [CI], 2.00-2.78), GFR ( or =120 mL/min per 1.73 m2), a mildly reduced GFR ( Conclusions Established cardiovascular disease risk factors are associated with the development of new-onset kidney disease. Patients with a mildly reduced GFR should be monitored for progression to kidney disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While dyslipidemia is a risk factor for progressive kidney disease (8,10,20,21)”
From Effects of Fibrates in Kidney Disease (2012) · cites this paper as [8]
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Cited by
Sorted by citations
Items 901–1,000 of 1,003
Li, Q., Zhu, H., Ma, X., & Zhao, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1528068 · Cited by 3
“Conversely, Caroline et al. (36) found that higher HDL-C levels were linked to less kidney disease progression in 2,585 U. S. adults.”
Xin, Y., Wang, Y.-M., Shu, Y.-Y., Liang, H.-Y., & Yang, Y.-M. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2499229 · Cited by 3
“For example, elevated levels of tG, ldl-C, and remnant cholesterol (RC), as well as reduced levels of Hdl-C, have been associated with an increased risk of CKd [8–11].”
Yang, Q., Zhang, M., Dong, Z., & Deng, F. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1507408 · Cited by 3
“For example, the Framingham study (16) found that a one-unit increase in BMI over 20 years correlates with a 20% higher risk of developing kidney disease.”
Association of Smoking with Chronic Kidney Disease Stages 3 to 5: A Mendelian Randomization Study
Zhang, Z., Zhang, F., Zhang, X., Lu, L., & Zhang, L. (2024) · Health Data Science · doi:10.34133/hds.0199 · Cited by 5
“In one-sample MR, 344,255 individuals of white British ancestry remained after excluding those lacking smoking data (79,654), who did not pass the quality control process (78,470), and missing genetic data (10; Fig.”
BackgroundKagota, S., Maruyama-Fumoto, K., Futokoro, R., & Shinozuka, K. (2024) · Journal of Vascular Diseases · doi:10.3390/jvd3040030 · Cited by 3
“Additionally, body mass index (BMI) is related to the development of kidney disease (odds ratio 1.23) in community-based populations [3].”
InfluentialImpairment of Cardiovascular Functional Capacity in Mild-to-Moderate Kidney Dysfunction
Lim, K., Nayor, M., Arroyo, E., Burney, H. N., Li, X.-C., Li, Y., Shah, R. V., Campain, J., Wan, D., Ting, S. M. S., et al. (2024) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.0000000000000548 · Cited by 3
“21 In the MGH-ExS cohort, creatinine levels were assessed within 14 days of invasive CPET as mandated by preprocedural policies.”
Association of hs-CRP with Serum Creatinine Levels in Chronic Kidney Diseases
Goriya, S., & Priya, N. (2024) · Indian Journal of Clinical Medicine · doi:10.1177/26339447241287048 · Cited by 3
Marouf, E. A.-K., Jameel, N. Q., & Moulood, I. F. (2024) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1369_23 · Cited by 3
Tang, L., Li, S.-M., Guo, X.-H., Lai, J.-H., Liu, P.-J., Fang, J.-M., & Liu, X. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03624-y · Cited by 3
“In view of the effect of HDL and the decrease level of HDL in CKD patients, some studies suggest that low HDL level is correlated with the development of CKD [32, 33].”
Tsuda, M., Hirata, A., Tokunaga, S., Masuda, T., Haji, S., Kimura, D., Nojiri, C., Nakashima, Y., Shiratsuchi, M., Kato, K., et al. (2022) · International journal of hematology · doi:10.1007/s12185-022-03433-6 · Cited by 3
“Because diabetes and habitual smoking are known risk factors for CKD [23], we used these variables as adjustment factors that could be obtained from the EMR.”
BackgroundInfluentialHonda, Y., Maruyama, Y., Nakamura, M., Nakao, M., Matsuo, N., Tanno, Y., Ohkido, I., Ikeda, M., & Yokoo, T. (2022) · Therapeutic apheresis and dialysis · doi:10.1111/1744-9987.13821 · Cited by 3
“The Framingham Offspring study showed that lower levels of high-density lipoprotein cholesterol (HDL-C) represented an independent risk factor for the development of incident CKD in a community-based population [12].”
BackgroundAdair, K. E., Ylitalo, K. R., Forsse, J. S., Funderburk, L., & Bowden, R. G. (2021) · Life · doi:10.3390/life11090904 · Cited by 3
“However, the ARIC study [30] and others [31,32] have found low HDL to be associated with renal decline, which is not consistent with our findings.”
ResultObesity Indices and the Risk of CKD
Tsuboi, N. (2021) · Internal medicine · doi:10.2169/internalmedicine.6921-20 · Cited by 3
“Obesity is recognized as not only a risk factor for the progression of chronic kidney disease (CKD), but also as an independent risk factor for the development of CKD (2).”
BackgroundReeve, J., Davis, M. B., & Twomey, P. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206713 · Cited by 3
Obesity as a cause of kidney disease - insights from Mendelian randomisation studiesPreprint
Xu, X.-G., Eales, J., Jiang, X., Sanderson, E., Scannali, D., Morris, A. P., Guzik, T., Charchar, F., Holmes, M., & Tomaszewski, M. (2020) · medRxiv · doi:10.1101/2020.09.13.20155234 · Cited by 3
AMY1 diploid copy number among end-stage renal disease patients
Grammatikopoulou, M., Gkiouras, K., Markaki, A., Gkouskou, K., Aivaliotis, M., Stylianou, K., & Bogdanos, D. (2020) · HORMONES · doi:10.1007/s42000-020-00199-6 · Cited by 3
“Indeed, BMI is one of the strongest risk factors for early-onset kidney disease [19] and the development of ESRD.”
BackgroundGosse, P., Segalas, C., Rubin, S., Boulestreau, R., Jacqmin-Gadda, H., Leffondré, K., Combe, C., & Cremer, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0245-4 · Cited by 3
Al‐Majdoub, M., Herzog, K., Daka, B., Magnusson, M., Råstam, L., Lindblad, U., & Spégel, P. (2018) · Metabolites · doi:10.3390/metabo8040078 · Cited by 3
“Hypertension is a proven risk factor for CKD [16], and the metabolome may therefore primarily reflect variations in eGFR that are secondary to hypertension.”
BackgroundInfluentialRaiPradeep, K., Punam, R., & Sonam, B. (2018) · Urology & Nephrology Open Access Journal · doi:10.15406/unoaj.2018.06.00227 · Cited by 3
Asuk, A., & Ugwu, M. (2018) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2018/42910 · Cited by 3
“In older men, chronic kidney disease (CKD) is an important medical problem that can even be life-threatening [18].”
BackgroundFiltrado glomerular estimado por fórmulas en pacientes obesos
Fernández, P., Chiurchiu, C., de Arteaga, J., Douthat, W., Campazzo, M., Luján, P., & Fuente, J. D. L. (2017) · doi:10.1016/j.nefrol.2017.03.002 · Cited by 3
Ybarra, J., Sánchez-Hernandez, J., Vilallonga, R., & Romeo, J. H. (2016) · European journal of internal medicine · doi:10.1016/j.ejim.2016.02.016 · Cited by 3
“Interestingly, the odds of incident of CKD after 18 years of follow-up among the participants of the Framingham Offspring Study have been reported to increase by 21% for every 1 standard deviation unit increment in BMI after controlling for age, diabetes, smoking and baseline eGFR [42].”
BackgroundTsirigoti, L., Kontogianni, M., Darema, M., Iatridi, V., Altanis, N., Poulia, K., Zavos, G., & Boletis, J. (2016) · Journal of human nutrition and dietetics (Print) · doi:10.1111/jhn.12289 · Cited by 3
Akwo, E., Cavanaugh, K., Ikizler, T., Blot, W., & Lipworth, L. (2015) · BMC Nutrition · doi:10.1186/s40795-015-0022-x · Cited by 3
Yamwong, S., Kitiyakara, C., Vathesatogkit, P., Saranburut, K., Chittamma, A., Cheepudomwit, S., Vanavanan, S., Akrawichien, T., & Sritara, P. (2015) · Nephrology · doi:10.1111/nep.12660 · Cited by 3
“Since there were no stored serum samples in 1985, the Jaffe creatinine of the 1985 survey was adjusted to the IDMS-standardized enzymatic assay by indirect calibration using stored serum samples obtained from the same cohort in 1997 as previously published.(17,19) First we established if there was any drift in the Jaf…”
MethodMalkina, A., Scherzer, R., Shlipak, M. G., Bacchetti, P., Tien, P., Grunfeld, C., Kosmiski, L. A., & Peralta, C. A. (2014) · HIV Medicine · doi:10.1111/hiv.12196 · Cited by 3
The Relationship of Chronic Renal Failure and Body Mass Index in Patients without Diabetes
Kristić, S., Zubović, S., & Zukić, F. (2013) · Medical archives · doi:10.5455/medarh.2013.67.405-406 · Cited by 3
“Together with an increased incidence of the disease also has increased the number of other pathological conditions caused by CRF including renal failure, cardiovascular diseases and lethal outcome.”
BackgroundInfluentialJia, D., Li, W., & Liu, J.-M. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9765-7 · Cited by 3
Mohebi, R., Bozorgmanesh, M., Sheikholeslami, F., Azizi, F., & Hadaegh, F. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12083 · Cited by 3
“It has been shown previously that risk factors for CVD also predict impaired kidney function.(32,33) We observed that excluding the smoking-associated CVD risk factors was higher among patients in the lower quintiles of eGFR.”
BackgroundThe skinny on obesity and end-stage renal disease.
Johansen, K. (2012) · Archives of Internal Medicine · doi:10.1001/2013.jamainternmed.917 · Cited by 3
Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Hirata, Y., Kiyosue, A., Takahashi, M., Satonaka, H., Nagata, D., Sata, M., Suzuki, E., & Nagai, R. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160543 · Cited by 3
“[7] 2,585 subjects 43 years old on average who did not show renal disease were followed up for 18.”
BackgroundFunción renal en hipertensos y/o diabéticos mayores de 65 años
Navarro, R. G. (2008) · doi:10.1016/s1138-3593(08)71874-4 · Cited by 3
Microalbuminuria and adiponectin in obese nondiabetic nonhypertensive people
Atta, M. I., Abdalla, N., & Ibrahim, A. (2016) · doi:10.4103/2356-8062.200938 · Cited by 3
Hussein, A. M., Rizk, M., Ahmed, A., Eltokhy, M., Senna, A., & Ataa, M. (2016) · doi:10.22192/ijarbs.2016.03.09.001 · Cited by 3
COPD and kidney disease: not so far apart?
Stratan, I., Covanţev, S., Mathioudakis, A. G., & Corlăteanu, A. (2026) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108761 · Cited by 2
Wang, P.-J., Meng, Y., Sun, Z., Li, J., & Tao, H.-L. (2026) · Int. J. Medical Informatics · doi:10.1016/j.ijmedinf.2026.106320 · Cited by 2
Worldwide impact of disease attributable to low physical activity for diabetes and kidney diseases
Ding, P., Qi, L., Wang, J.-L., Tang, M., & Weng, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1499381 · Cited by 2
“In addition, it is noteworthy that diabetes serves as the predominant cause of kidney disease (3).”
Suwabe, T., Torres, V. E., Vaughan, L. E., Madsen, C. D., Harris, P. C., Shimada, Y., Nakatani, S., Hoshino, J., Nishio, S., Mochizuki, T., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.12.019 · Cited by 2
Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study.
Abdollahi, A., Sani, M. M., Shabani, M., Matuck, B. S., Blaha, M., Wu, C. O., Ambale-Venkatesh, B., Budoff, M., Strom, J., Rotter, J. I., et al. (2025) · European journal of internal medicine · doi:10.1016/j.ejim.2025.03.037 · Cited by 2
Choi, J.-Y., & Yang, Y.-M. (2024) · Medicine · doi:10.1097/md.0000000000038769 · Cited by 2
Yoon, Y., Kim, Y.-M., Lee, S., Shin, B., Kim, H.-L., Chung, J., & Son, M. (2023) · Nutrients · doi:10.3390/nu15245039 · Cited by 2
“In addition, it stands as an independent contributor to CKD advancement and is linked with albuminuria [30,31].”
BackgroundGlycemic index of a nutritional supplement designed for people with chronic kidney disease
Rachana, B., Shobana, S., Lalithya, P. V., Sudha, V., Vinita, S., Gayathri, R., Kalpana, N., Ranjit, M. A., & Viswanathan, M. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3495 · Cited by 2
“, 2004), two major risk factors for progression toward chronic kidney disease (Fox et al., 2004).”
BackgroundCho, Y., Huh, J., Moon, S., Kim, Y., Kim, Y.-H., Han, K., Kang, J., Lee, S.-J., & Ihm, S. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13164 · Cited by 2
Bae, E. H., Lim, S. Y., Yang, E. M., Oh, T. R., Choi, H. S., Kim, C. S., Kwon, S., Kim, B., Han, K.-D., & Kim, S. W. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.313 · Cited by 3
“Two large epidemiologic studies in the United States reported a positive association between BMI and ESRD, and these studies analyzed a broad spectrum of BMI among a large, diverse sample of participants with long-term follow-up for ESRD [7,8].”
BackgroundAssociation between liver stiffness measurement by transient elastography and chronic kidney disease
Chan, Y., Chang, S.-S., Wu, J. L., Wang, S.-T., & Yu, C.-S. (2022) · Medicine · doi:10.1097/md.0000000000028658 · Cited by 2
Hepatitis C infection and chronic kidney disease among Hispanics/Latinos
Wong, E., Ricardo, A., Rosas, S., Lash, J., & Franceschini, N. (2021) · Medicine · doi:10.1097/md.0000000000028089 · Cited by 2
“[4] Previous works have explored the impact of HCV on risk of CKD, but studies have often used different case definitions of bothHCV+ and reduced kidney function.”
BackgroundInfluentialPreventing Progression of Chronic Kidney Disease with Plant-Based Diet
Gunadhar, P. (2021) · Clinical Medical Reviews and Case Reports · doi:10.23937/2378-3656/1410365 · Cited by 5
Aker, A., Eitan, A., Saliba, W., Jaffe, R., & Zafrir, B. (2021) · Coronary Artery Disease · doi:10.1097/mca.0000000000001105 · Cited by 2
Lian, S.-H., Hsu, B., Wang, J., & Chen, M. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_49_21 · Cited by 2
“Predictably, MetS increased the occurrence of DM and CVD and established cardiometabolic risk factors that promote CKD development [25].”
BackgroundCardiovascular Risk Assessment in Hypertensive patients: A Perspective Observative Study
Kumar, T., P, P., Sabiya, S., & Eswaraiah, M. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00767 · Cited by 2
Kakar, A., Kakar, N., Durand, A., Mouelhi, Y., & Gentile, S. (2021) · doi:10.21203/rs.3.rs-199379/v1 · Cited by 2
“A strong dose-response relationship between BMI and risk of ESRD was found in men, but not in women [41].”
BackgroundInfluentialIntegrating preventive cardiology in primary care
Alaujan, B. S., Zamzami, B. A., Ababtain, H. A., Altalouhi, F. M., Alshammari, . H., Alenizi, E. S., Aldossary, G. F., Alshaibani, . S., Alowaidan, . R., Alharbi, A. F., et al. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5ns1.15060 · Cited by 3
Frequency, Co-morbidities and outcome of acute kidney injury in elderly admitted patients
Mahmud, H., & Dastoor, H. D. D. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.5.2429 · Cited by 2
Kitiyakara, C., Saranburut, K., Thongmung, N., Chittamma, A., Vanavanan, S., Donsakul, K., Sritara, P., & Vathesatogkit, P. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2019-212718 · Cited by 2
Wang, M.-J., Sun, X., Ni, L., Zhang, M.-M., Zhang, J.-Y., Ye, G., Jin, L., Wang, X.-F., & Chen, J. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s250535 · Cited by 2
Duran, M., Elçik, D., Inanç, M., Yarlıoglues, M., Çelik, I. E., Oksuz, F., & Murat, S. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0319 · Cited by 2
Obesidade e doença renal: aspectos fisiopatológicos
Schelb, J. E., de Paula, R. D., Ezequiel, D. G. A., & Costa, M. B. (2019) · HU Revista · doi:10.34019/1982-8047.2018.v44.13982 · Cited by 2
Chmielewski, J., Khalsa, D., & Carmody, J. (2019) · Nephron · doi:10.1159/000497780 · Cited by 2
Wu, L., Guo, V., Wong, C., Kung, K., Han, L., Wang, X.-L., & Luo, Y. (2017) · Nephrology · doi:10.1111/nep.12921 · Cited by 2
Sumi, T., Oguri, M., Fujimaki, T., Horibe, H., Kato, K., Matsui, K., Takeuchi, I., Murohara, T., & Yamada, Y. (2017) · Biomedical Reports · doi:10.3892/br.2016.831 · Cited by 2
“The prevalence of obesity is increasing worldwide, and is a risk factor of numerous diseases, including CKD (38).”
Febuxostat for Asymptomatic Hyperuricemia in CKD.
Mome, R., & Bakinde, N. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.09.035 · Cited by 2
“We wonder how much confounding effect these parameters have on the results, considering that they are established independent risk factors for a decline in kidney function.(4,5) We agree that more studies with larger population size are needed to fully explore not only the clinical benefits of febuxostat, but also adv…”
BackgroundRombopoulos, G., Panitti, E., Varounis, C., Katsinas, C., Stefanidis, I., & Goumenos, D. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1151777 · Cited by 2
Función renal en niños con obesidad y síndrome metabólico
Verónica, J., Miramontes, R., Ortega, L. A. D., Malagón, A. D., Araujo, C., & Rosas, A. (2015) · Acta Universitaria · doi:10.15174/au.2015.765 · Cited by 2
“El perímetro de la cintura abdominal tiene una asociación significativa con la glomerulopatia del obeso (Fox et al., 2004).”
BackgroundRioja, J., Moreno, T., Coca, I., Jiménez-Villodres, M., Rodríguez-Morata, A., & Valdivielso, P. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.02.004 · Cited by 2
Buğra, O. (2014) · doi:10.5606/tgkdc.dergisi.2014.7780 · Cited by 2
“[14] Tüm dünyada 135 milyon diyabet hastası vardır ve bu sayının 2025 yılında 300 milyon olması beklenmektedir.[15] Koroner baypas cerrahisi yapılan hastalarda DM oranı %30 olarak saptanmıştır.”
Management of Atrial Fibrillation: Direct Factor IIa and Xa Inhibitors or “Warfarin Shotgun”?
Halperin, J. L., & Goyette, R. E. (2012) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.21346 · Cited by 2
Impaired fasting glucose as a treatment target in diabetes management
OLIVEROS, R. A., Zion, A. S., Rosenberg, Y., Selvaraj, C. L., & CHILTON, R. J. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0066-0 · Cited by 2
“Results from the Modifi cation of Diet in Renal Disease study [ 38 ] did not fi nd a signifi cant correlation with the development of new-onset kidney disease and prediabetes (IFG 1.08 [0.64–1.82]).”
InfluentialEvaluating the relationship between daily self-monitoring of blood glucose and healthcare costs
Ho, M., Joish, V., White, G., Alder, S., & Oderda, G. (2007) · Journal of Medical Economics · doi:10.3111/200710017026 · Cited by 2
Classification of chronic kidney disease based on evaluation of kidney function
Johnson, D. (2005) · doi:10.1111/j.1440-1797.2005.00487_5.x · Cited by 2
Pulmonary Hypertension in Chronic Kidney Disease and End-Stage Renal Disease
Maddipati, V., & Chakinala, M. (2020) · Pulmonary Hypertension · doi:10.1007/978-3-030-52787-7_11 · Cited by 2
Cystatin C level in pre-diabetic and diabetic patients
Akın, Ş. (2017) · doi:10.14744/jkartaltr.2017.13914 · Cited by 2
“[12] This condition might be related to insulin resistance,[13] increased renal glukoneogenesis,[14] endothelial dysfunction and/or chronic inflammation, oxidative stress[14,15] and activation of the renin- angiyotensin system.”
BackgroundPlatelet turnover and function in end-stage renal disease
Filipov, P., Božić, D., Mijović, R., & Mitić, G. (2016) · doi:10.2298/vsp160720374f · Cited by 2
Chang, A. R., & Kramer, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00028-x · Cited by 3
Ectopic Scrotum: A Rare Clinical Entity
Leão, R., Pereira, B., & Coelho, H. (2012) · doi:10.3834/uij.1944-5784.2012.12.01 · Cited by 2
Medical Evaluation of the Living Kidney Donor
Lin, J. (2012) · doi:10.1007/978-1-4614-0008-0_3 · Cited by 2
“Being overweight or obese have been identifi ed as independent risk factors for development of chronic kidney disease [ 12 ] and progression to end-stage renal disease [ 15 ] and it is possible that transplanted kidneys from overweight donors have a greater degree of early focal segmental sclerosis as previously repor…”
BackgroundResultBautista, L. (2010) · American Public Health Association eBooks · doi:10.2105/9780875531922ch11 · Cited by 2
Dyslipidemias in Chronic Kidney Disease: Pathophysiology and Emerging Therapies
Capón, I. M., Lerma, E. V., Anandh, U., So, P. N., & Hassanein, M. (2026) · Indian Journal of Nephrology · doi:10.25259/ijn_711_2025 · Cited by 1
Ebrahimi, N., Masrouri, S., Fardoost, S., Azizi, F., & Hadaegh, F. (2026) · Journal of Human Hypertension · doi:10.1038/s41371-025-01107-4 · Cited by 1
Chen, F.-Y., Pei, D., Kuo, C.-H., Huang, L.-Y., Jhou, M.-J., & Liang, Y.-J. (2025) · Medicine · doi:10.1097/md.0000000000044732 · Cited by 1
“[28] The similar tendency could also be noted in obese T2D.”
Honoré, P., Joseph, A., & Lee, H. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08028-3 · Cited by 1
“The global rise in obesity presents new and complex challenges in critical care [1, 2].”
Cai, X., Ju, M., Jiang, X.-Y., Ge, S., Han, Y., Lin, S.-M., Peng, H., Li, M., & Wang, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1554663 · Cited by 1
“Previous studies have linked age, hypertension (HTN), diabetes, and dyslipidemia with renal deterioration (4).”
Shankar, M., Bashyam, S., Reddy, G., A., K., & G., S. (2025) · International Journal of Nephrology · doi:10.1155/ijne/5578625 · Cited by 1
“Diabetes and hypertension are important and well-known risk factors [6].”
A Risk Prediction Model for New-Onset Chronic Kidney Disease in the Elderly
Luo, W., Lei, L., Lai, J., Liu, Y., Liang, H., Yan, S., Gao, X., Chen, H., Nai, W., Zhang, X., et al. (2024) · American Journal of Nephrology · doi:10.1159/000541510 · Cited by 1
“Fox et al. [39], in a community-based cohort study involving the Framingham offspring cohort, similarly did not fi nd proteinuria to be a risk factor for developing CKD [39, 40].”
Ma, X., Lv, J., Zhang, S., Zhang, X.-F., Lin, X., Li, S.-X., Yang, L., Xue, F., Yi, F., & Zhang, T. (2024) · Nutrients · doi:10.3390/nu16142355 · Cited by 1
“While hypertension is a well-established risk factor for CKD [24,49], limited research has explored whether habitual iron supplementation amplifies the risk of CKD in individuals with hypertension, especially in those taking antihypertensive medication.”
BackgroundKamel, A. (2024) · Fayoum University Medical journal · doi:10.21608/fumj.2023.242065.1275 · Cited by 1
Eriksen, B., Fasiolo, M., Mathisen, U., Jenssen, T., Stefansson, V., & Melsom, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-41181-7 · Cited by 1
Paradoxical mortality differential of HDL cholesterol
Mukhopadhyay, J., Mallik, D., & Garg, S. (2023) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v14i5.50292
Xuan, Y., Xi, G., Shen, Y., Wang, S., Gao, P., Tang, D., Xun, Wang, Zhu, F., Lu, L.-Q., et al. (2022) · Annals of Case Reports · doi:10.29011/2574-7754.100970 · Cited by 1
“A previous study showed that increased vulnerability of the glomerular microcirculation to elevated systemic blood pressure is postulated to contribute to adverse effects of obesity on the kidney [43].”
BackgroundZahrani, R. A. A., Harthi, F. A., Butt, F. I., Solami, A. D. A., Kurdi, A. A., Otaibi, T. A. A., Alahmadi, A. H., Alhozali, H., Ankawi, G., & Gaddoury, M. A. (2022) · Cureus · doi:10.7759/cureus.28694 · Cited by 1
“The direct effect of increased body mass index (BMI) and obesity on renal function has also been studied in different aspects by variable studies in different populations [8-10].”
BackgroundPersil-Ozkan, O., Cebeci, E., Sevim, Y., Savaş, Y., Ozturk, S., & Tayfur, M. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03976 · Cited by 1
Norman, G., Woodiwiss, A., Peterson, V. R., Gomes, M., Sareli, P., & Norton, G. (2020) · Cardiovascular Journal of Africa · doi:10.5830/cvja-2019-057 · Cited by 1
Kidney Diseases in the Elderly
So, S., Stevenson, J. K., & Lee, V. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-96998-5_16 · Cited by 3
Marković, D., Trgo, G., Prkačin, I., Fabijanić, D., & Kovacic, V. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1851-8 · Cited by 1
Evaluating Kidney Function in Elderly Population: A Cross-Sectional Study in Primary Health Care
Tsimtsiou, Z., Karakoula, K., Efthymiadou, E., Asimakopoulos, A., Fardi, B., Birka, S., & Dantsi, F. (2017) · doi:10.4172/2167-7182.1000384 · Cited by 1
Park, S., Moon, K., Ryoo, J., Yoon, J., Lee, E., Lee, K. O., Oh, I., & Choi, J.-M. (2016) · Family Medicine & Medical Science Research · doi:10.4172/2327-4972.1000207 · Cited by 1
dos Santos, M. V. R., Ferreira, G., de Oliveira, E. C. P., Kreimer, F., Campos, J., & Ferraz, Â. (2014) · Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · doi:10.1590/s0102-6720201400s100017 · Cited by 1
“Patel N. et al.21 analyzed the urine of 58 patients being 52 RYGB, and six biliopancreatic diversion with duodenal switch, in six month interval post-surgery.”
InfluentialHypertension résistante et maladie rénale chronique : épidémiologie et pronostic
Seidowsky, A., Massy, Z. A., Metzger, M., & Stengel, B. (2014) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2013.12.006 · Cited by 2
The Safety Debate Regarding Dietary Protein in Strength Athletes
Lowery, L. M. (2012) · CRC Press eBooks · doi:10.1201/b11928-4 · Cited by 1
The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic
Davies, J., Crook, M., Wierzbicki, A., & Goldsmith, D. (2011) · International Urology and Nephrology · doi:10.1007/s11255-010-9819-3 · Cited by 1
“The Framingham offspring study [ 12 ] found only low HDL-C levels to be associated with onset of CKD, while the results of the Helsinki Heart Study [13] showed a relationship between lipids and CKD onset only in hypertensive individuals, in a primary prevention cohort with”
ResultEnfermedad renal crónica: clasificación, etiopatogenia y factores pronósticos
Calderon-Gonzalez, C., & Garcia-Fernandez, N. (2011) · doi:10.1016/s0304-5412(11)70105-6 · Cited by 1
Metadata
- Authors
- Fox, C. S.
- Affiliations
- Framingham Heart Study (US)
- Corresponding author
- Fox, Caroline S.
- ORCID
- Fox, Caroline S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-02-18
- Volume
- 291
- Issue
- 7
- Pages
- 844
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1992283514
- Cited by
- 1,241
- References
- 0
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 50 · 2023: 37 · 2022: 53 · 2021: 62 · 2020: 62 · 2019: 47 · 2018: 49 · 2017: 59 · 2016: 81 · 2015: 49 · 2014: 79 · 2013: 83 · 2012: 68
- FWCI
- 28.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (N01‐HC25195)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- chronic kidney disease, risk factors, glomerular filtration rate, diabetes mellitus, smoking, body mass index, age, MDRD equation, cardiovascular disease, end-stage renal disease, community-based cohort, risk prediction model, renal function decline, hyperlipidemia, antihypertensive drugs, antihypertensive medication adherence
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Longitudinal Studies, Male, Middle Aged, Risk Factors, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review